Predictors of chronic arthralgia after chikungunya virus infection: a systematic review and meta-analysis

Clicks: 31
ID: 326594
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #37 of 78 articles by views in international journal of travel medicine and global health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
ABSTRACT Background Chikungunya is an expanding global health threat, with chronic arthralgia representing the main long-term driver of disability. Although many studies have assessed post-chikungunya outcomes, evidence remains fragmented and contradictory. We aimed to identify reproducible predictors of chronic arthralgia (≥3 months) after laboratory-confirmed chikungunya and to distinguish stable prognostic signals from context-dependent associations. Methods We searched PubMed, Embase, Cochrane Library, and BVS/LILACS from inception to Feb 6, 2026, without restrictions. Eligible studies compared participants with and without chronic arthralgia at follow-up and reported extractable baseline or acute-phase factors. Two reviewers independently screened records, extracted data, and assessed risk of bias using QUIPS. Random-effects restricted maximum likelihood meta-analyses pooled odds ratios and mean differences, with subgroup analyses by follow-up window. PROSPERO: CRD420251169320. Results Of 1784 records, 29 studies were included, comprising 4108 participants: 1838 with chronic arthralgia and 2230 without. After harmonization, 22 predictors were meta-analyzed. The most consistent associations were female sex (OR 2.08, 95% CI 1.77–2.46; I2=8.3%), comorbidity presence (1.99, 1.55–2.55; I2=0%), and high blood pressure (1.52, 1.13–2.04; I2=33.4%). In contrast, several acute-phase manifestations and treatment-related markers showed less stable, timing-dependent, or study-sensitive associations. Overall risk of bias was high in most studies and moderate in the remainder. Conclusions Chronic post-chikungunya arthralgia was most reproducibly associated with readily identifiable baseline host factors, rather than with a uniform acute-severity phenotype. These findings suggest that risk stratification should not rely only on acute symptom burden, and that pre-existing vulnerability may define a clinically important high-risk group. Point-of-care identification of patients with these characteristics could support prioritization of follow-up and resource allocation during outbreaks, inform post-outbreak surveillance and guideline development, and may guide future burden-based vaccination strategies in endemic settings.
Reference Key
openalex_W7204554623 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal international journal of travel medicine and global health
Year 2026
DOI
10.1093/jtm/taag078
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.